Multiscale cancer modeling

Annual Review of Biomedical Engineering

Volumn 13, Issue , 2011, Pages 127-155

  Deisboeck, Thomas S ^a   Wang, Zhihui ^a   MacKlin, Paul ^b   Cristini, Vittorio ^c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Cancer systems biology; Clinical translation; Continuum; Discrete; Hybrid; Personalized medicine

Indexed keywords

CLINICAL TRANSLATION; CONTINUUM; DISCRETE; HYBRID; PERSONALIZED MEDICINE; SYSTEMS BIOLOGY;

BIOMECHANICS; DISEASES; INNOVATION; MODELS; USER INTERFACES;

MATHEMATICAL MODELS;

DOXORUBICIN;

ARTICLE; ATOMIC SCALE; BIOCHEMISTRY; BIOMECHANICS; BIOPHYSICS; CANCER CHEMOTHERAPY; CELL INTERACTION; CELL VIABILITY; COMPUTATIONAL FLUID DYNAMICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LUNG NON SMALL CELL CANCER; MACROSCOPIC SCALE; METHODOLOGY; MICROSCOPIC SCALE; MODEL; MOLECULAR SCALE; MULTISCALE CANCER MODELING; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ALGORITHMS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DISEASE PROGRESSION; HUMANS; INDIVIDUALIZED MEDICINE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; SYSTEMS BIOLOGY;

EID: 79960490878     PISSN: 15239829     EISSN: 15454274     Source Type: Book Series    
DOI: 10.1146/annurev-bioeng-071910-124729     Document Type: Article

References (122)

1. Balmain A, Gray J, Ponder B. 2003. The genetics and genomics of cancer. Nat. Genet. 33(Suppl.):238-44 (Pubitemid 36278834)
2. Bissell MJ, Radisky D. 2001. Putting tumours in context. Nat. Rev. Cancer 1:46-54 (Pubitemid 33741880)
3. Hynes RO. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110:673-87 (Pubitemid 35283958)
4. Giles R, Loberg RD. 2006. Can we target the chemokine network for cancer therapeutics? Curr. Cancer Drug Targets 6:659-70 (Pubitemid 44875960)
5. Deisboeck TS, Berens ME, Kansal AR, Torquato S, Stemmer-Rachamimov AO, Chiocca EA. 2001. Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model. Cell Prolif. 34:115-34 (Pubitemid 32374712)
6. Popel AS, Hunter PJ. 2009. Systems biology and physiome projects. Wiley Interdiscip. Rev. Syst. Biol. Med. 1:153-58
7. Schnell S, Grima R,Maini PK. 2007. Multiscale modeling in biology:New insights into cancer illustrate how mathematical tools are enhancing the understanding of life from the smallest scale to the grandest. Am. Sci. 95:134-42
8. Komarova NL. 2005. Mathematical modeling of tumorigenesis: mission possible. Curr. Opin. Oncol. 17:39-43 (Pubitemid 40179910)
9. Anderson ARA, Quaranta V. 2008. Integrative mathematical oncology. Nat. Rev. Cancer 8:227-34 (Pubitemid 351301842)
10. Lowengrub JS, Frieboes HB, Jin F, Chuang YL, Li X, et al. 2010. Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity 23:R1-9
11. Cristini V, Lowengrub J. 2010. Multiscale Modeling of Cancer: An Integrated Experimental and Mathematical Modeling Approach. Cambridge: Cambridge Univ. Press. 300 pp.
12. Hunter PJ,Crampin EJ,Nielsen PM. 2008. Bioinformatics,multiscale modeling and the IUPS Physiome Project. Brief. Bioinforma. 9:333-43 (Pubitemid 351890829)
13. Zewail A, ed. 2008. Physical Biology: From Atoms to Medicine. London, UK: Imperial College Press
14. Di Ventura B, Lemerle C, Michalodimitrakis K, Serrano L. 2006. From in vivo to in silico biology and back. Nature 443:527-33 (Pubitemid 44527283)
15. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK. 2006. Physicochemical modelling of cell signalling pathways. Nat. Cell Biol. 8:1195-203 (Pubitemid 44660581)
16. Walker DC, Southgate J. 2009. The virtual cell-a candidate coordinator for 'middle-out' modelling of biological systems. Brief. Bioinforma. 10:450-61
17. Sanga S, FrieboesHB, ZhengX,Gatenby R, Bearer EL, Cristini V. 2007. Predictive oncology: a review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growth. NeuroImage 37(Suppl. 1):S120-34 (Pubitemid 47239436)
18. Sloot PM, Hoekstra AG. 2010. Multiscale modelling in computational biomedicine. Brief. Bioinforma. 11:142-52
19. Araujo RP, McElwain DL. 2004. A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull. Math. Biol. 66:1039-91
20. Tracqui P. 2009. Biophysical models of tumour growth. Rep. Prog. Phys. 72:056701
21. Gatenby RA, Silva AS, Gillies RJ, Frieden BR. 2009. Adaptive therapy. Cancer Res. 69:4894-903
22. Christiansen JJ, Rajasekaran AK. 2006. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66:8319-26
23. Wang Z, Deisboeck TS. 2008. Computationalmodeling of brain tumors:Discrete, continuum or hybrid? Sci. Model. Simul. 15:381-93
24. An G. 2008. Introduction of an agent-based multiscale modular architecture for dynamic knowledge representation of acute inflammation. Theor. Biol. Med. Model. 5:11
25. SchallerG,Meyer-HermannM. 2006. Continuum versus discretemodel: a comparison for multicellular tumour spheroids. Philos. Trans. R. Soc. Lond. Ser. A 364:1443-64
26. Berg OG, Paulsson J, Ehrenberg M. 2000. Fluctuations and quality of control in biological cells: zeroorder ultrasensitivity reinvestigated. Biophys. J. 79:1228-36
27. WolkenhauerO, Auffray C, Baltrusch S, BluthgenN, Byrne H, et al. 2010. Systems biologists seek fuller integration of systems biology approaches in new cancer research programs. Cancer Res. 70:12-13
28. Hanahan D,Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70 (Pubitemid 30046295)
29. Jorissen RN, Walker F, PouliotN,Garrett TP, Ward CW, Burgess AW. 2003. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 284:31-53 (Pubitemid 36331965)
30. Shawver LK, Slamon D, Ullrich A. 2002. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1:117-23
31. Schulze WX,Deng L,MannM. 2005. Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol. Syst. Biol. 1:2005.0008
32. Liu Y, Purvis J, Shih A, Weinstein J, Agrawal N, Radhakrishnan R. 2007. A multiscale computational approach to dissect early events in the Erb family receptor mediated activation, differential signaling, and relevance to oncogenic transformations. Ann. Biomed. Eng. 35:1012-25
33. Purvis J, Ilango V, Radhakrishnan R. 2008. Role of network branching in eliciting differential short-term signaling responses in the hypersensitive epidermal growth factor receptor mutants implicated in lung cancer. Biotechnol. Prog. 24:540-53 (Pubitemid 351843413)
34. Shih AJ, Purvis J, Radhakrishnan R. 2008. Molecular systems biology of ErbB1 signaling: bridging the gap through multiscale modeling and high-performance computing. Mol. Biosyst. 4:1151-59
35. Telesco SE, RadhakrishnanR. 2009. Atomistic insights into regulatorymechanisms of theHER2tyrosine kinase domain: a molecular dynamics study. Biophys. J. 96:2321-34
36. Postovit LM, Seftor EA, Seftor RE, HendrixMJ. 2006. Influence of themicroenvironment on melanoma cell fate determination and phenotype. Cancer Res. 66:7833-36
37. Wang Z, Bordas V, Deisboeck TS. 2011. Discovering molecular targets in cancer with multiscale modeling. Drug Dev. Res. 72:42-52
38. Athale C, Mansury Y, Deisboeck TS. 2005. Simulating the impact of a molecular 'decision-process' on cellular phenotype and multicellular patterns in brain tumors. J. Theor. Biol. 233:469-81 (Pubitemid 40320594)
39. Dittmar T, Husemann A, Schewe Y, Nofer JR, Niggemann B, et al. 2002. Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. FASEB J. 16:1823-25
40. Athale CA, Deisboeck TS. 2006. The effects of EGF-receptor density on multiscale tumor growth patterns. J. Theor. Biol. 238:771-79 (Pubitemid 43175828)
41. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD. 1990. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res. 50:6039-44
42. Zhang L, Athale CA, Deisboeck TS. 2007. Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J. Theor. Biol. 244:96-107 (Pubitemid 44751755)
43. Alarcon T, Byrne HM,Maini PK. 2004. A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells. J. Theor. Biol. 229:395-411 (Pubitemid 38844943)
44. Zhang L, Strouthos CG, Wang Z, Deisboeck TS. 2009. Simulating brain tumor heterogeneity with a multiscale agent-based model: linking molecular signatures, phenotypes and expansion rate. Math. Comput. Model. 49:307-19
45. Steinbach JP, Klumpp A,Wolburg H,Weller M. 2004. Inhibition of epidermal growth factor receptor signaling protects human malignant glioma cells from hypoxia-induced cell death. Cancer Res. 64:1575-78
46. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, et al. 2004. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350:2129-39
47. Wang Z, Birch CM, Deisboeck TS. 2008. Cross-scale sensitivity analysis of a non-small-cell lung cancer model: linking molecular signaling properties to cellular behavior. Biosystems 92:249-58
48. Wang Z, Bordas V, Sagotsky J, Deisboeck TS. 2010. Identifying therapeutic targets in a combined EGFR-TGFβR signaling cascade using a multiscale agent-based cancer model. Math. Med. Biol. In press, doi:10.1093/imammb/dqq023
49. Wang Z, Zhang L, Sagotsky J, Deisboeck TS. 2007. Simulating non-small-cell lung cancer with a multiscale agent-based model. Theor. Biol. Med. Model. 4:50
50. Santos SD, Verveer PJ, Bastiaens PI. 2007. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 9:324-30 (Pubitemid 46344612)
51. Wang Z, Birch CM, Sagotsky J, Deisboeck TS. 2009. Cross-scale, cross-pathway evaluation using an agent-based non-small-cell lung cancer model. Bioinformatics 25:2389-96
52. Galle J, Loeffler M, Drasdo D. 2005. Modeling the effect of deregulated proliferation and apoptosis on the growth dynamics of epithelial cell populations in vitro. Biophys. J. 88:62-75 (Pubitemid 40070658)
53. Bru A, Albertos S, Luis Subiza J, Garcia-Asenjo JL, Bru I. 2003. The universal dynamics of tumor growth. Biophys. J. 85:2948-61
54. Albini A, Sporn MB. 2007. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 7:139-47 (Pubitemid 46160989)
55. Gerlee P, Anderson ARA. 2007. An evolutionary hybrid cellular automaton model of solid tumour growth. J. Theor. Biol. 246:583-603 (Pubitemid 46719261)
56. Gerlee P, Anderson ARA. 2008. A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype. J. Theor. Biol. 250:705-22
57. Gerlee P, Anderson ARA. 2009. Evolution of cell motility in an individual-based model of tumour growth. J. Theor. Biol. 259:67-83
58. Hood JD, Cheresh DA. 2002. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2:91-100 (Pubitemid 37328796)
59. Ramis-Conde I, Drasdo D, Anderson ARA, Chaplain MAJ. 2008. Modeling the influence of the Ecadherin-β-catenin pathway in cancer cell invasion: a multiscale approach. Biophys. J. 95:155-65
60. Qi J, Wang J, Romanyuk O, Siu CH. 2006. Involvement of Src family kinases in N-cadherin phosphorylation and β-catenin dissociation during transendothelial migration of melanoma cells. Mol. Biol. Cell 17:1261-72
61. Ramis-Conde I, Chaplain MAJ, Anderson ARA, Drasdo D. 2009. Multiscale modelling of cancer cell intravasation: the role of cadherins in metastasis. Phys. Biol. 6:16008
62. Anderson ARA, Chaplain MAJ, Rejniak KA, eds. 2007. Single-Cell-Based Models in Biology and Medicine. Basel, Switz.: Birkḧauser. 349 pp.
63. Zheng X,Wise SM, Cristini V. 2005. Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method. Bull. Math. Biol. 67:211-59 (Pubitemid 40234527)
64. Frieboes HB, Lowengrub JS,Wise S, Zheng X, Macklin P, et al. 2007. Computer simulation of glioma growth and morphology. NeuroImage 37(Suppl. 1):S59-70 (Pubitemid 47239426)
65. Wise SM, Lowengrub JS, Frieboes HB, Cristini V. 2008. Three-dimensional multispecies nonlinear tumor growth: I. Model and numerical method. J. Theor. Biol. 253:524-43
66. Bearer EL, Lowengrub JS, Frieboes HB, Chuang YL, Jin F, et al. 2009. Multiparameter computational modeling of tumor invasion. Cancer Res. 69:4493-501
67. Macklin P, McDougall S, Anderson ARA, Chaplain MAJ, Cristini V, Lowengrub J. 2009. Multiscale modelling and nonlinear simulation of vascular tumour growth. J. Math. Biol. 58:765-98
68. Frieboes HB, Jin F, Chuang YL, Wise SM, Lowengrub JS, Cristini V. 2010. Three-dimensional multispecies nonlinear tumor growth: II. Tumor invasion and angiogenesis. J. Theor. Biol. 264:1254-78
69. Macklin P. 2010. Biological background. See Reference 11, pp. 8-23
70. Anderson ARA, Chaplain MAJ. 1998. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol. 60:857-99 (Pubitemid 28427465)
71. McDougall SR, Anderson ARA, Chaplain MAJ, Sherratt JA. 2002. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies. Bull. Math. Biol. 64:673-702 (Pubitemid 36072687)
72. Chaplain MAJ, Anderson ARA. 2004. Mathematical modelling of tumour-induced angiogenesis: network growth and structure. Cancer Treat. Res. 117:51-75
73. Chaplain MAJ, McDougall SR, Anderson ARA. 2006. Mathematical modeling of tumor-induced angiogenesis. Annu. Rev. Biomed. Eng. 8:233-57 (Pubitemid 44314817)
74. McDougall SR, Anderson ARA, Chaplain MAJ. 2006. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J. Theor. Biol. 241:564-89 (Pubitemid 44041121)
75. Macklin P, Lowengrub J. 2005. Evolving interfaces via gradients of geometry-dependent interior Poisson problems: application to tumor growth. J. Comput. Phys. 203:191-220 (Pubitemid 40004135)
76. Macklin P, Lowengrub J. 2006. An improved geometry-aware curvature discretization for level set methods: application to tumor growth. J. Comput. Phys. 215:392-401
77. Macklin P, Lowengrub J. 2007. Nonlinear simulation of the effect of microenvironment on tumor growth. J. Theor. Biol. 245:677-704 (Pubitemid 46454401)
78. Macklin P, Lowengrub J. 2008. A new ghost cell/level set method for moving boundary problems: application to tumor growth. J. Sci. Comput. 35:266-99
79. Ward JP, King JR. 1997. Mathematical modelling of avascular-tumour growth. Math.Med. Biol. 14:39-69 (Pubitemid 127463789)
80. Ward JP, King JR. 1999. Mathematical modelling of avascular-tumour growth: II. Modelling growth saturation. Math. Med. Biol. 16:171-211
81. Smallbone K, Gavaghan DJ, Gatenby RA, Maini PK. 2005. The role of acidity in solid tumour growth and invasion. J. Theor. Biol. 235:476-84 (Pubitemid 40780937)
82. Gatenby RA, Smallbone K,Maini PK, Rose F, Averill J, et al. 2007. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br. J. Cancer 97:646-53 (Pubitemid 47339892)
83. Smallbone K, Gatenby RA, Maini PK. 2008. Mathematical modelling of tumour acidity. J. Theor. Biol. 255:106-12
84. Macklin P, Kim J, Tomaiuolo G, Edgerton ME, Cristini V. 2009. Agent-based modeling of ductal carcinoma in situ: application to patient-specific breast cancer modeling. In Computational Biology: Issues and Applications in Oncology, ed. T Pham, pp. 77-112. New York: Springer
85. Macklin P, Edgerton ME, Cristini V. 2010. Agent-based cell modeling: application to breast cancer. See Reference 11, pp. 206-34
86. Cristini V, Frieboes HB, Gatenby R, Caserta S, Ferrari M, Sinek J. 2005. Morphologic instability and cancer invasion. Clin. Cancer Res. 11:6772-79
87. Frieboes HB, Zheng X, Sun CH, Tromberg B, Gatenby R, Cristini V. 2006. An integrated computational/experimental model of tumor invasion. Cancer Res. 66:1597-604 (Pubitemid 43259943)
88. Jin F, Chuang Y-L, Cristini V, Lowengrub J. 2010. Hybrid continuum-discrete tumor models. See Reference 11, pp. 123-52
89. Macklin P, Edgerton ME, Lowengrub JS, Cristini V. 2010. Discrete cell modeling. See Reference 11, pp. 88-122
90. Armstrong NJ, Painter KJ, Sherratt JA. 2006. A continuum approach to modelling cell-cell adhesion. J. Theor. Biol. 243:98-113 (Pubitemid 44465967)
91. Sherratt JA, Gourley SA, Armstrong NJ, Painter KJ. 2009. Boundedness of solutions of a nonlocal reaction-diffusion model for adhesion in cell aggregation and cancer invasion. Euro. J. Appl. Math. 20:123-44
92. Gerisch A, Chaplain MAJ. 2008. Mathematical modelling of cancer cell invasion of tissue: local and nonlocal models and the effect of adhesion. J. Theor. Biol. 250:684-704
93. Sinek J, Frieboes H, Zheng X, Cristini V. 2004. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles. Biomed.Microdevices 6:297-309 (Pubitemid 39545749)
94. Sinek JP, Sanga S,Zheng X, FrieboesHB, Ferrari M, Cristini V. 2009. Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation. J. Math. Biol. 58:485-510
95. FrieboesH, Edgerton ME, Fruehauf JP, Rose FRAJ, Worrall LK, et al. 2009. Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res. 69:4484-92
96. Kim Y, Stolarska MA, Othmer HG. 2007. A hybrid model for tumor spheroid growth in vitro: I. Theoretical development and early results. Math. Models Methods Appl. Sci. 17:1773-98
97. Stolarska MA, Kim Y, Othmer HG. 2009. Multiscale models of cell and tissue dynamics. Philos. Trans. R. Soc. Lond. Ser. A 367:3525-53
98. Dallon JC, Othmer HG. 2004. How cellular movement determines the collective force generated by the Dictyostelium discoideum slug. J. Theor. Biol. 231:203-22 (Pubitemid 39221873)
99. Kohl P, Noble D. 2009. Systems biology and the virtual physiological human. Mol. Syst. Biol. 5:292
100. Beard DA, Bassingthwaighte JB, Greene AS. 2005. Computational modeling of physiological systems. Phys. Genomics 23:1-3; discussion 4
101. Sible JC, Tyson JJ. 2007. Mathematical modeling as a tool for investigating cell cycle control networks. Methods 41:238-47 (Pubitemid 44960838)
102. Ashyraliyev M, Fomekong-Nanfack Y, Kaandorp JA, Blom JG. 2009. Systems biology: parameter estimation for biochemical models. FEBS J. 276:886-902
103. Mendes P, Kell D. 1998. Nonlinear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation. Bioinformatics 14:869-83 (Pubitemid 29041543)
104. Moles CG, Mendes P, Banga JR. 2003. Parameter estimation in biochemical pathways: a comparison of global optimization methods. Genome Res. 13:2467-74
105. Price ND, Papin JA, Schilling CH, Palsson BO. 2003. Genome-scale microbial in silico models: the constraints-based approach. Trends Biotechnol. 21:162-69 (Pubitemid 36397984)
106. Zi Z, Klipp E. 2007. Constraint-based modeling and kinetic analysis of the Smad dependent TGF-β signaling pathway. PLoS ONE 2:e936
107. Deisboeck TS, Zhang L, Yoon J, Costa J. 2009. In silico cancer modeling: Is it ready for prime time? Nat. Clin. Pract. Oncol. 6:34-42
108. ErbanR, FrewenTA, Wang X, Elston TC,Coifman R, et al. 2007. Variable-free exploration of stochastic models: a gene regulatory network example. J. Chem. Phys. 126:155103
109. Gear CW, Kevrekidis IG. 2003. Telescopic projective methods for parabolic differential equations. J. Comput. Phys. 187:95-109 (Pubitemid 36515573)
110. Kolpas A, Moehlis J, Kevrekidis IG. 2007. Coarse-grained analysis of stochasticity-induced switching between collective motion states. Proc. Natl. Acad. Sci. USA 104:5931-35
111. E WN, Engquist B, Huang ZY. 2003. Heterogeneous multiscale method: a general methodology for multiscale modeling. Phys. Rev. B 67:092101
112. Ren WQ, E WN. 2005. Heterogeneous multiscale method for the modeling of complex fluids and microfluidics. J. Comput. Phys. 204:1-26
113. MultiCellXML: An open XML data standard for multicell agent models. http://multicellxml.sourceforge. net
114. CBO: The Cell Behavior Ontology. http://cbo.biocomplexity.indiana.edu
115. Antezana E, Kuiper M, Mironov V. 2009. Biological knowledge management: the emerging role of the Semantic Web technologies. Brief. Bioinforma. 10:392-407
116. CViT: The Center for the Development of a Virtual Tumor. http://www.cvit.org/
117. Deisboeck TS, Zhang L, Martin S. 2007. Advancing cancer systems biology: introducing the Center for the Development of a Virtual Tumor, CViT. Cancer Informa. 5:1-8
118. Li C, Courtot M, Le Novere N, Laibe C. 2010. BioModels.net Web Services, a free and integrated toolkit for computational modelling software. Brief. Bioinforma. 11:270-77
119. Sagotsky JA, Zhang L, Wang Z, Martin S, Deisboeck TS. 2008. Life Sciences and the web: a new era for collaboration. Mol. Syst. Biol. 4:201
120. Wang X, Gorlitsky R, Almeida JS. 2005. From XML to RDF: how Semantic Web technologies will change the design of 'omic' standards. Nat. Biotechnol. 23:1099-103 (Pubitemid 41486391)
121. Butcher EC, Berg EL, Kunkel EJ. 2004. Systems biology in drug discovery. Nat. Biotechnol. 22:1253-59
122. Deisboeck TS. 2009. Personalizing medicine: a systems biology perspective. Mol. Syst. Biol. 5:249